L'IMPERIO, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 6.563
EU - Europa 5.292
AS - Asia 4.110
SA - Sud America 453
AF - Africa 58
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.488
Nazione #
US - Stati Uniti d'America 6.428
SG - Singapore 1.723
IT - Italia 1.668
RU - Federazione Russa 970
HK - Hong Kong 888
DE - Germania 755
CN - Cina 626
SE - Svezia 538
IE - Irlanda 462
BR - Brasile 377
VN - Vietnam 345
GB - Regno Unito 157
FR - Francia 141
AT - Austria 136
ID - Indonesia 104
KR - Corea 103
UA - Ucraina 95
FI - Finlandia 93
CA - Canada 88
IN - India 79
NL - Olanda 76
DK - Danimarca 59
TR - Turchia 49
BD - Bangladesh 37
MX - Messico 33
IQ - Iraq 30
PK - Pakistan 28
BE - Belgio 26
AR - Argentina 20
JP - Giappone 17
CH - Svizzera 15
GR - Grecia 15
SA - Arabia Saudita 15
ZA - Sudafrica 15
VE - Venezuela 13
PL - Polonia 12
LT - Lituania 10
MA - Marocco 10
PE - Perù 9
PT - Portogallo 9
CZ - Repubblica Ceca 8
PH - Filippine 8
UY - Uruguay 8
AU - Australia 7
EC - Ecuador 7
ES - Italia 7
AE - Emirati Arabi Uniti 6
CO - Colombia 6
EG - Egitto 6
TN - Tunisia 6
AL - Albania 5
CL - Cile 5
HU - Ungheria 5
JO - Giordania 5
LV - Lettonia 5
PY - Paraguay 5
RS - Serbia 5
UZ - Uzbekistan 5
BG - Bulgaria 4
IL - Israele 4
IR - Iran 4
JM - Giamaica 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
AM - Armenia 3
AZ - Azerbaigian 3
BO - Bolivia 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GA - Gabon 3
KZ - Kazakistan 3
LB - Libano 3
NP - Nepal 3
OM - Oman 3
PA - Panama 3
SC - Seychelles 3
AO - Angola 2
BH - Bahrain 2
CR - Costa Rica 2
ET - Etiopia 2
EU - Europa 2
KG - Kirghizistan 2
MU - Mauritius 2
MY - Malesia 2
NZ - Nuova Zelanda 2
SN - Senegal 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BT - Bhutan 1
EE - Estonia 1
HN - Honduras 1
IM - Isola di Man 1
IS - Islanda 1
KE - Kenya 1
LK - Sri Lanka 1
LY - Libia 1
ML - Mali 1
NG - Nigeria 1
Totale 16.483
Città #
Ann Arbor 1.476
Singapore 928
Hong Kong 885
Ashburn 696
Frankfurt am Main 468
Milan 461
Dublin 446
Fairfield 385
Chandler 346
Santa Clara 294
Wilmington 284
New York 223
Woodbridge 219
Houston 199
Hefei 169
Seattle 153
Princeton 132
Dearborn 128
Cambridge 114
Jakarta 103
Ho Chi Minh City 99
Vienna 97
Seoul 92
Moscow 90
Shanghai 89
Hanoi 82
Jacksonville 80
Munich 80
Beijing 61
Los Angeles 55
Dong Ket 54
Nanjing 54
Kent 53
Altamura 52
Helsinki 51
Lawrence 50
London 49
Rome 38
Nuremberg 37
Monza 34
Florence 32
Guangzhou 32
Toronto 31
Lissone 29
São Paulo 29
Boardman 25
Brussels 23
Nanchang 23
San Diego 23
Pune 22
Council Bluffs 21
Cinisello Balsamo 20
Naples 20
Turin 19
Chicago 18
Falls Church 18
Istanbul 18
Bologna 17
Düsseldorf 17
Ottawa 17
Andover 16
Bari 16
Lappeenranta 15
Padova 15
Sesto San Giovanni 15
Shenyang 15
Turku 15
Austin 14
Hebei 14
Genoa 13
Jinan 13
Cilavegna 12
Dallas 12
Phoenix 12
The Dalles 12
Baghdad 11
Brescia 11
Centro Municipality 11
Hải Dương 11
Xi'an 11
Amsterdam 10
Atlanta 10
Caronno Pertusella 10
Desio 10
Dhaka 10
Hyderabad 10
Romola 10
San Mateo 10
Tianjin 10
Athens 9
Columbus 9
Da Nang 9
Fremont 9
Haiphong 9
Hangzhou 9
Karachi 9
Lachine 9
Rio de Janeiro 9
San Francisco 9
Terni 9
Totale 10.313
Nome #
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 325
MALDI imaging in Fabry nephropathy: a multicenter study 319
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 299
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 298
The proteomic landscape of renal tumors 292
Kidney Involvement 280
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 272
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 272
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 270
The putative role of MALDI-MSI in the study of Membranous Nephropathy 268
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 266
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 265
Proteomics for the study of new biomarkers in Fabry disease: State of the art 235
Proteome analysis in thyroid pathology 229
Cytopathology of Bronchoalveolar Lavages in COVID-19 Pneumonia: A Pilot Study 229
Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse: A case report 222
Sequential MALDI-HiPLEX-IHC and Untargeted Spatial Proteomics Mass Spectrometry Imaging to Detect Proteomic Alterations Associated with Tumour Infiltrating Lymphocytes 219
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 215
Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis 206
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 204
PD-L1 Testing and Squamous Cell Carcinoma of the Head and Neck: A Multicenter Study on the Diagnostic Reproducibility of Different Protocols 200
"Pathologists in Venice - Real World Cases for an Immersive Training Experience": Education, Gaming, and Show 199
Nodal monoclonal CD5-positive B-lymphocytosis and toxoplasma lymphadenitis: Another variant in the spectrum of infectious lymphadenitis in patients with chronic leukemia/small lymphocytic lymphoma 198
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 195
Debating the pros and cons of computational pathology at the European Congress of Pathology (ECP) 2024 195
Immunosuppression in idiopathic membranous nephropathy: A double-edge sword 191
Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies 186
Diagnostic performances of the acr-tirads system in thyroid nodules triage: A prospective single center study 183
Displaced Cartilage Within Lymph Node Parenchyma Is a Novel Biopsy Site Change in Resected Mediastinal Lymph Nodes Following EBUS-TBNA 179
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 177
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 164
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 160
Anticoagulant-related nephropathy: a pathological note 160
Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient 159
Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity 157
Digital transition in pathology lab: a survey from the Lombardy region 156
Monoclonal gammopathy of renal significance: Systemic involvement by benign condition 155
More than an ‘atypical’ phenotype: dual molecular diagnosis of autoimmune lymphoproliferative syndrome and Becker muscular dystrophy 154
Machine learning streamlines the morphometric characterization and multi-class segmentation of nuclei in different follicular thyroid lesions: everything in a NUTSHELL 153
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 151
Destructuring glomerular diseases with structured deposits: challenges in the precision medicine era 151
MALDI-MS imaging in the study of glomerulonephritis 147
#EBUSTwitter: Novel use of social media for conception, coordination, and completion of an international, multicenter pathology study 143
Dissecting the histological features of lupus nephritis highlights new common patterns of injury in class III/IV 141
The putative role of MALDI-MSI in the study of Membranous Nephropathy 141
Liquid-based shaking of core needle biopsy samples for the molecular characterization of tumors: A fallback in cytopathology 140
Use of diagnostic criteria from acr and eu-tirads systems to improve the performance of cytology in thyroid nodule triage 136
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 135
Autopsia di Innocenzo XII. Un’attestazione dell’utilizzo del microscopio in ambito necroscopico nel XVII secolo 134
Improvements in digital pathology equipment for renal biopsies: updating the standard model 131
Kidney Function, CKD Causes, and Histological Classification 131
The putative role of MALDI-MSI in the study of Membranous Nephropathy 130
Tumour incidence in Fabry disease: A cross-sectional study 128
Response to: 'Correspondence on 'Bowman's capsule rupture on renal biopsy improves the outcome prediction of ANCA-associated glomerulonephritis classifications'' by Hakroush and Tampe 124
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 122
The role of digital and integrative pathology for the detection of translocations: a narrative review 121
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 121
Imaging molecolare a livello cellulare: possiamo predire la risposta alla terapia nella Nefropatia Membranosa? 116
Digital counting of tissue cells for molecular analysis: the QuANTUM pipeline 115
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 115
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 114
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 114
Digital pathology for the routine diagnosis of renal diseases: a standard model 114
The therapeutic potential of an allosteric non-competitive CXCR1/2 antagonist for diabetic nephropathy 113
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 113
MALDI-MS Imaging in Membranous Nephropathy: from the research to the clinical laboratory? 112
A Mass Spectrometry Imaging-based multiomics approach to map the tumour-immune landscape of clear cell Renal Cell Carcinoma and gain insights into resistance to immunotherapy 111
The Complex Cyto-Molecular Landscape of Thyroid Nodules in Pediatrics 110
Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology 110
An Indeterminate for Malignancy FNA Report Does Not Increase the Surgical Risk of Incidental Thyroid Carcinoma 110
Artificial intelligence–based algorithms for the diagnosis of prostate cancer: A systematic review 108
High spatial resolution MALDI-MSI in the search for proteomic indicators of response to therapy in Membranous Nephropathy 108
Pathologist Validation of a Machine Learning-Derived Feature for Colon Cancer Risk Stratification 104
Goodpasture syndrome and anti-glomerular basement membrane disease 103
JAK2-mutated Langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib 101
Un nuovo approccio basato sull’Imaging con Spettrometria di Massa per la sottotipizzazione dell’amiloidosi renale [A novel mass spectrometry imaging based approach for the subtyping of renal amyloidosisn] 100
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome 100
The evolving landscape of anatomic pathology 99
Improving the Annotation Process in Computational Pathology: A Pilot Study with Manual and Semi-automated Approaches on Consumer and Medical Grade Devices 98
Cost analysis of archives in the pathology laboratories: from safety to management 98
The Puzzle of Preimplantation Kidney Biopsy Decision-Making Process: The Pathologist Perspective 93
Renal involvement in eosinophilic granulomatosis with polyangiitis 93
MALDI-MS Imaging Application in Thyroid FNA: Challenges and Perspectives 93
MALDI-MS imaging in the search for proteomic indicators of response to therapy in membranous nephropathy 92
Bowman's capsule rupture on renal biopsy improves the outcome prediction of ANCA-associated glomerulonephritis classifications 89
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 88
Economic assessment of NGS testing workflow for NSCLC in a healthcare setting 88
The spectrum of the cytopathological features of primary effusion lymphoma and human herpes virus 8-related lymphoproliferative disorders 87
Different clusters in patients with lupus podocytopathy identified by clinical-pathological characteristics 85
Time for a full digital approach in nephropathology: a systematic review of current artificial intelligence applications and future directions 84
Pathology Laboratory Archives: Conservation Quality of Nucleic Acids and Proteins for NSCLC Molecular Testing 84
Real-world digital pathology: considerations and ruminations of four young pathologists 83
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology 80
Systemic vasculitis involving the kidney: the nephropathologist's point of view 79
Spatial transcriptome of a germinal center plasmablastic burst hints at MYD88/CD79B mutants-enriched diffuse large B-cell lymphomas 79
Delving deeper into the Tumour Microenvironment: a MS-driven spatial multiomics approach to provide new molecular insights into immune-tumour cell communication 79
Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis 78
Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions 78
Unveiling the Role of Additional Histological Parameters in ANCA-Associated Vasculitis 78
The slow-paced digital evolution of pathology: lights and shadows from a multifaceted board 76
Totale 15.105
Categoria #
all - tutte 66.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.167


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.704 76 66 123 152 159 170 166 198 148 159 120 167
2021/20221.186 145 130 127 68 68 101 26 79 32 83 123 204
2022/20231.923 183 503 192 146 106 274 53 144 163 41 81 37
2023/20241.944 67 84 86 121 188 441 349 70 175 40 87 236
2024/20256.810 232 514 624 276 467 287 329 219 640 997 883 1.342
2025/20261.252 1.252 0 0 0 0 0 0 0 0 0 0 0
Totale 17.102